Evotec SE American Depositary Shares

EVO XNAS

Market Cap

690M

Short interest (Jul 15)

0.0%

Net Short (Jul 27 ): 0.0%

Borrow Fee

10.97%

↑ 21.6%

Available Shares

200K

↑ 88.4%

Price Chart

Company Overview

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Company Info

Exchange: NASDAQ
CIK: 0001412558
Asset Type: ADRC

Market Data

Market Cap: $689,064,832
Employees: 4,553
Status: Active

Short Interest

Current Borrow Fee 10.97%
Range: 10.97% - 10.97%
Available Shares 200K
Range: 100K - 150K

Recent Changes

Fee Change: ↑ 3.5%
Available Change: ↓ 12.5%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime